Efficacy and safety of angiotensin II receptor blockers in elderly patients with mild to moderate hypertension.

The role of the renin-angiotensin-aldosterone system in the pathogenesis of hypertensive disease has long been recognized, and the interruption of this cascade with angiotensin-converting enzyme-I has been beneficial in the management of hypertension. Recently, a new class of drugs, the angiotensin receptor blockers, emerged, enlarging the antihypertensive armamentarium. Since elderly patients are more prone to adverse drug reactions, in this paper we review several trials, most of which were of short duration, on the efficacy and safety of angiotensin receptor blockers in the geriatric population with mild to moderate hypertension. These studies established that the drugs are well-tolerated, safe, and in most instances as efficacious as other classes of antihypertensive medications. Combination therapy with angiotensin receptor blockers and hydrochlorothiazide was additive, without any significant effect on the safety profile.
AuthorsC E Okereke, F H Messerli
JournalThe American journal of geriatric cardiology (Am J Geriatr Cardiol) 2001 Jan-Feb Vol. 10 Issue 1 Pg. 42-9 ISSN: 1076-7460 [Print] United States
PMID11413935 (Publication Type: Journal Article, Review)
Chemical References
  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents
  • Aged
  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents (adverse effects, therapeutic use)
  • Clinical Trials as Topic
  • Humans
  • Hypertension (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: